Stocks and Investing Stocks and Investing
Fri, June 21, 2024
Thu, June 20, 2024

Alethia Young Reiterated (ARWR) at Buy on, Jun 20th, 2024


Published on 2024-10-28 12:01:36 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Cantor Fitzgerald, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy on, Jun 20th, 2024.

Alethia has made no other calls on ARWR in the last 4 months.



There are 4 other peers that have a rating on ARWR. Out of the 4 peers that are also analyzing ARWR, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Monday, May 13th, 2024


These are the ratings of the 2 analyists that currently disagree with Alethia


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Tuesday, June 11th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Monday, June 3rd, 2024
Contributing Sources